Relevium Technologies Inc. RLLVF
0.01 USD 0.00 (+0.00%)
Regular-session close
0.22 Day range 0.22
0.006 52-week range 0.22
- YTD
- 0.00%
- 1 year
- 0.00%
News
globenewswire.com Relevium Technologies Completes Shares-For-Debt Transactions MONTREAL, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that it has completed its…
globenewswire.com Relevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in Shares MONTREAL, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), announced today it has received…
globenewswire.com Relevium Announces Settlement of the Outstanding Notes MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), announces today it has reached an…
globenewswire.com Relevium Announces Shareholder Townhall and Conference Call MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), is pleased to invite all shareholders,…
globenewswire.com Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), announces today the maturity of its…
globenewswire.com Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), and its' wholly-owned subsidiary,…
globenewswire.com Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves MONTREAL, May 05, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), whose primary mandate is to focus on…
globenewswire.com Biocannabix Enters Into LOI With IAM Health GmbH MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), and its' wholly-owned subsidiary,…
globenewswire.com Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “6BX ”) (the “Company” or “Relevium”), is pleased to announce the company has…
globenewswire.com Relevium Announces Investor Relations Conference Call MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “ 6BX ”) (the “Company” or “Relevium”), is pleased to invite all shareholders,…
globenewswire.com Relevium Reports Interim First Quarter Results for the Three-Month Period Ended September 30, 2020 MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “ 6BX ”) (the “Company” or “Relevium”), is pleased to report the completion of…
globenewswire.com Relevium Reports Fiscal Year Ended June 30, 2020 Results MONTREAL, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“ RLV ”, OTCQB:“ RLLVF ” and Frankfurt: “ 6BX ”) (the “Company” or “Relevium”), is pleased to report the completion of…
globenewswire.com Relevium Issues Corporate Update on MCTO and Filing of Financial Statements MONTREAL, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces an update on its ongoing disclosure…
globenewswire.com Relevium Issues Corporate Update on MCTO and Filing of Financial Statements MONTREAL, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces an update on its ongoing disclosure…
globenewswire.com Relevium Issues Corporate Update on MCTO and Operations MONTREAL, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to provide an update on all major…
globenewswire.com Relevium Provides Regulatory Update on Annual Financials and Management Cease Trade Order MONTREAL, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is providing an update to its previously…
globenewswire.com Relevium Provides Update to Management Cease Trade Order MONTREAL, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is providing an update to its previously…
globenewswire.com Relevium Announces Delay in Filing Annual Audited Financial Statements MONTREAL, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces that its annual financial statements…
